메뉴 건너뛰기




Volumn 63, Issue 10, 2014, Pages 1081-1091

Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?

Author keywords

Adoptive cell transfer; Melanoma antigens; Metastatic melanoma; PIVAC 13; Tumor infiltrating lymphocytes

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; HEALTH CARE QUALITY; HUMAN; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE TRANSFUSION; MELANOMA; PATHOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; TRANSPLANTATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84928587963     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-014-1580-5     Document Type: Review
Times cited : (41)

References (63)
  • 1
    • 84555218419 scopus 로고    scopus 로고
    • Cancer immunotherapy comes of age
    • PID: 22042955, COI: 1:CAS:528:DC%2BC38Xhslygs7k%3D
    • Topalian SL, Weiner GJ, Pardoll DM (2011) Cancer immunotherapy comes of age. J Clin Oncol 29:4828–4836
    • (2011) J Clin Oncol , vol.29 , pp. 4828-4836
    • Topalian, S.L.1    Weiner, G.J.2    Pardoll, D.M.3
  • 3
    • 0022473607 scopus 로고
    • A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
    • PID: 3489291, COI: 1:STN:280:DyaL28zhsFygsQ%3D%3D
    • Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233:1318–1321
    • (1986) Science , vol.233 , pp. 1318-1321
    • Rosenberg, S.A.1    Spiess, P.2    Lafreniere, R.3
  • 4
    • 0037829421 scopus 로고    scopus 로고
    • Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
    • PID: 12843795
    • Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA (2003) Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 26:332–342
    • (2003) J Immunother , vol.26 , pp. 332-342
    • Dudley, M.E.1    Wunderlich, J.R.2    Shelton, T.E.3    Even, J.4    Rosenberg, S.A.5
  • 5
    • 84879085212 scopus 로고    scopus 로고
    • Analysis of V delta1 T cells in clinical grade melanoma-infiltrating lymphocytes
    • PID: 23243593
    • Donia M, Ellebaek E, Andersen MH, Straten PT, Svane IM (2012) Analysis of V delta1 T cells in clinical grade melanoma-infiltrating lymphocytes. Oncoimmunology 1:1297–1304
    • (2012) Oncoimmunology , vol.1 , pp. 1297-1304
    • Donia, M.1    Ellebaek, E.2    Andersen, M.H.3    Straten, P.T.4    Svane, I.M.5
  • 22
    • 84855748551 scopus 로고    scopus 로고
    • Characterization and comparison of “Standard” and “Young” tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution
    • Donia M, Junker N, Ellebaek E, Andersen MH, Straten PT, Svane IM (2011) Characterization and comparison of “Standard” and “Young” tumor infiltrating lymphocytes for adoptive cell therapy at a Danish Translational Research Institution. Scand J Immunol 75:157–167
    • (2011) Scand J Immunol , vol.75 , pp. 157-167
    • Donia, M.1    Junker, N.2    Ellebaek, E.3    Andersen, M.H.4    Straten, P.T.5    Svane, I.M.6
  • 24
    • 84859179612 scopus 로고    scopus 로고
    • Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE(R) bioreactor
    • PID: 22475724
    • Somerville RP, Devillier L, Parkhurst MR, Rosenberg SA, Dudley ME (2012) Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE(R) bioreactor. J Transl Med 10:69
    • (2012) J Transl Med , vol.10 , pp. 69
    • Somerville, R.P.1    Devillier, L.2    Parkhurst, M.R.3    Rosenberg, S.A.4    Dudley, M.E.5
  • 26
    • 84872616852 scopus 로고    scopus 로고
    • Methods to improve adoptive T-cell therapy for melanoma: IFN-gamma enhances anticancer responses of cell products for infusion
    • PID: 23014345, COI: 1:CAS:528:DC%2BC38XhsVSlsbrN
    • Donia M, Hansen M, Sendrup SL, Iversen TZ, Ellebaek E, Andersen MH, Straten P, Svane IM (2013) Methods to improve adoptive T-cell therapy for melanoma: IFN-gamma enhances anticancer responses of cell products for infusion. J Invest Dermatol 133:545–552
    • (2013) J Invest Dermatol , vol.133 , pp. 545-552
    • Donia, M.1    Hansen, M.2    Sendrup, S.L.3    Iversen, T.Z.4    Ellebaek, E.5    Andersen, M.H.6    Straten, P.7    Svane, I.M.8
  • 27
    • 84862490985 scopus 로고    scopus 로고
    • Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
    • PID: 22555974, COI: 1:CAS:528:DC%2BC38XhtVGns7%2FO
    • Yao X, Ahmadzadeh M, Lu YC, Liewehr DJ, Dudley ME, Liu F, Schrump DS, Steinberg SM, Rosenberg SA, Robbins PF (2012) Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood 119:5688–5696
    • (2012) Blood , vol.119 , pp. 5688-5696
    • Yao, X.1    Ahmadzadeh, M.2    Lu, Y.C.3    Liewehr, D.J.4    Dudley, M.E.5    Liu, F.6    Schrump, D.S.7    Steinberg, S.M.8    Rosenberg, S.A.9    Robbins, P.F.10
  • 29
    • 34249868241 scopus 로고    scopus 로고
    • Adoptive T cell therapy for cancer in the clinic
    • PID: 17549249, COI: 1:CAS:528:DC%2BD2sXmsVWktb8%3D
    • June CH (2007) Adoptive T cell therapy for cancer in the clinic. J Clin Invest 117:1466–1476
    • (2007) J Clin Invest , vol.117 , pp. 1466-1476
    • June, C.H.1
  • 34
    • 84886667225 scopus 로고    scopus 로고
    • A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma
    • PID: 24194775, COI: 1:STN:280:DC%2BC2c7jsVWqsA%3D%3D
    • Labarriere N, Fortun A, Bellec A, Khammari A, Dreno B, Saiagh S, Lang F (2013) A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma. Clin Dev Immunol 2013:932318
    • (2013) Clin Dev Immunol , vol.2013 , pp. 932318
    • Labarriere, N.1    Fortun, A.2    Bellec, A.3    Khammari, A.4    Dreno, B.5    Saiagh, S.6    Lang, F.7
  • 35
    • 33750940238 scopus 로고    scopus 로고
    • Phase I study of adoptive T-cell therapy using antigen-specific CD8 + T cells for the treatment of patients with metastatic melanoma
    • PID: 17075125, COI: 1:CAS:528:DC%2BD28Xht1Gnur3O
    • Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J, Andreesen R (2006) Phase I study of adoptive T-cell therapy using antigen-specific CD8 + T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 24:5060–5069
    • (2006) J Clin Oncol , vol.24 , pp. 5060-5069
    • Mackensen, A.1    Meidenbauer, N.2    Vogl, S.3    Laumer, M.4    Berger, J.5    Andreesen, R.6
  • 38
    • 0037058993 scopus 로고    scopus 로고
    • Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells
    • PID: 12427970, COI: 1:CAS:528:DC%2BD38Xps1ensLk%3D
    • Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD (2002) Adoptive T cell therapy using antigen-specific CD8 + T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 99:16168–16173
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 16168-16173
    • Yee, C.1    Thompson, J.A.2    Byrd, D.3    Riddell, S.R.4    Roche, P.5    Celis, E.6    Greenberg, P.D.7
  • 47
    • 62749185585 scopus 로고    scopus 로고
    • Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma
    • PID: 19270751
    • Wallen H, Thompson JA, Reilly JZ, Rodmyre RM, Cao J, Yee C (2009) Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. PLoS ONE 4:e4749
    • (2009) PLoS ONE , vol.4 , pp. e4749
    • Wallen, H.1    Thompson, J.A.2    Reilly, J.Z.3    Rodmyre, R.M.4    Cao, J.5    Yee, C.6
  • 50
    • 33750343038 scopus 로고    scopus 로고
    • Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion
    • PID: 17056585, COI: 1:CAS:528:DC%2BD28XhtFSns7bI
    • Powell DJ Jr, Dudley ME, Hogan KA, Wunderlich JR, Rosenberg SA (2006) Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion. J Immunol 177:6527–6539
    • (2006) J Immunol , vol.177 , pp. 6527-6539
    • Powell, D.J.1    Dudley, M.E.2    Hogan, K.A.3    Wunderlich, J.R.4    Rosenberg, S.A.5
  • 52
    • 84888334918 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
    • PID: 24072401, COI: 1:CAS:528:DC%2BC3sXhsFKjsbnL
    • Jordan KR, Amaria RN, Ramirez O, Callihan EB, Gao D, Borakove M, Manthey E, Borges VF, McCarter MD (2013) Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients. Cancer Immunol Immunother 62:1711–1722
    • (2013) Cancer Immunol Immunother , vol.62 , pp. 1711-1722
    • Jordan, K.R.1    Amaria, R.N.2    Ramirez, O.3    Callihan, E.B.4    Gao, D.5    Borakove, M.6    Manthey, E.7    Borges, V.F.8    McCarter, M.D.9
  • 53
    • 84856760496 scopus 로고    scopus 로고
    • Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
    • PID: 22120757, COI: 1:CAS:528:DC%2BC38XhsVWmurk%3D
    • Umansky V, Sevko A (2012) Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation. Cancer Immunol Immunother 61:275–282
    • (2012) Cancer Immunol Immunother , vol.61 , pp. 275-282
    • Umansky, V.1    Sevko, A.2
  • 54
    • 84901281224 scopus 로고    scopus 로고
    • Chemotherapeutic targeting of cancer-induced immunosuppressive cells
    • PID: 24778417, COI: 1:CAS:528:DC%2BC2cXnvF2hs70%3D
    • Alizadeh D, Larmonier N (2014) Chemotherapeutic targeting of cancer-induced immunosuppressive cells. Cancer Res 74:2663–2668
    • (2014) Cancer Res , vol.74 , pp. 2663-2668
    • Alizadeh, D.1    Larmonier, N.2
  • 56
    • 79953310550 scopus 로고    scopus 로고
    • White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy
    • PID: 21325070, COI: 1:CAS:528:DC%2BC3MXktVOisr0%3D
    • Weber J, Atkins M, Hwu P, Radvanyi L, Sznol M, Yee C (2011) White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy. Clin Cancer Res 17:1664–1673
    • (2011) Clin Cancer Res , vol.17 , pp. 1664-1673
    • Weber, J.1    Atkins, M.2    Hwu, P.3    Radvanyi, L.4    Sznol, M.5    Yee, C.6
  • 63
    • 84873819555 scopus 로고    scopus 로고
    • Which drug, and when, for patients with BRAF-mutant melanoma?
    • PID: 23369684, COI: 1:CAS:528:DC%2BC3sXhvFSksrg%3D
    • Jang S, Atkins MB (2013) Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol 14:e60–e69
    • (2013) Lancet Oncol , vol.14 , pp. e60-e69
    • Jang, S.1    Atkins, M.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.